Rumah » Semua » Prakiraan Saham » Zhengye Biotechnology Holding Limited Class A Ordinary Shares Ramalan

Zhengye Biotechnology Holding Limited Class A Ordinary Shares Ramalan: Besok, Pekan, Bulan, 5 Tahun

Diperbarui: April 22 · 2026 at 07:03 UTC
▼ -3.10%Market Cap $43.62M · Technical analysis Bearish · Focus area Price + volatility

Ringkasan Prakiraan

Jangka waktuPrediksi HargaMasa laluHistorisWawasan
Besok$0.9319 +1.24%Kemarin$0.9157 -0.52%Tomorrow's Zhengye Biotechnology Holding Limited Class A Ordinary Shares (ZYBT) setup is anchored to $0.9205 and targets $0.9319 (+1.24%). The near-term read is upside; watch $0.9481 / $0.8929 because daily realized volatility is about 6.38%.
Tomorrow's Zhengye Biotechnology Holding Limited Class A Ordinary Shares (ZYBT) setup is anchored to $0.9205 and targets $0.9319 (+1.24%). The near-term read is upside; watch $0.9481 / $0.8929 because daily realized volatility is about 6.38%.
Pekan$0.9559 +3.85%Minggu lalu$0.9056 -1.62%The 7-day Zhengye Biotechnology Holding Limited Class A Ordinary Shares model moves from $0.9056 to $0.9559 (+3.85%). It gives upside momentum context for this stock, so breaks around $0.9481 / $0.8929 matter more than a single tick.
The 7-day Zhengye Biotechnology Holding Limited Class A Ordinary Shares model moves from $0.9056 to $0.9559 (+3.85%). It gives upside momentum context for this stock, so breaks around $0.9481 / $0.8929 matter more than a single tick.
Bulan$0.9960 +8.20%Bulan Lalu$0.8888 -3.44%The 1-month Zhengye Biotechnology Holding Limited Class A Ordinary Shares target is $0.9960 (+8.20%), compared with the live reference near $0.9205. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk.
The 1-month Zhengye Biotechnology Holding Limited Class A Ordinary Shares target is $0.9960 (+8.20%), compared with the live reference near $0.9205. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk.
Tahun$1.06 +14.72%Tahun Lalu$0.8636 -6.18%The 1-year Zhengye Biotechnology Holding Limited Class A Ordinary Shares scenario points to $1.06 (+14.72%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates.
The 1-year Zhengye Biotechnology Holding Limited Class A Ordinary Shares scenario points to $1.06 (+14.72%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates.
5 Tahun$1.20 +30.00%5 Tahun Lalu$0.8045 -12.60%The 5-year Zhengye Biotechnology Holding Limited Class A Ordinary Shares view is $1.20 (+30.00%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path.
The 5-year Zhengye Biotechnology Holding Limited Class A Ordinary Shares view is $1.20 (+30.00%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path.
Besok$0.9319 +1.24%
Kemarin$0.9157 -0.52%
Tomorrow's Zhengye Biotechnology Holding Limited Class A Ordinary Shares (ZYBT) setup is anchored to $0.9205 and targets $0.9319 (+1.24%). The near-term read is upside; watch $0.9481 / $0.8929 because daily realized volatility is about 6.38%.
Pekan$0.9559 +3.85%
Minggu lalu$0.9056 -1.62%
The 7-day Zhengye Biotechnology Holding Limited Class A Ordinary Shares model moves from $0.9056 to $0.9559 (+3.85%). It gives upside momentum context for this stock, so breaks around $0.9481 / $0.8929 matter more than a single tick.
Bulan$0.9960 +8.20%
Bulan Lalu$0.8888 -3.44%
The 1-month Zhengye Biotechnology Holding Limited Class A Ordinary Shares target is $0.9960 (+8.20%), compared with the live reference near $0.9205. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk.
Tahun$1.06 +14.72%
Tahun Lalu$0.8636 -6.18%
The 1-year Zhengye Biotechnology Holding Limited Class A Ordinary Shares scenario points to $1.06 (+14.72%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates.
5 Tahun$1.20 +30.00%
5 Tahun Lalu$0.8045 -12.60%
The 5-year Zhengye Biotechnology Holding Limited Class A Ordinary Shares view is $1.20 (+30.00%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path.
Risk notice:This forecast is informational only, not financial advice; accuracy depends on volatility, liquidity, macro events, and other external factors.

Bagan Harga

HistorisRamalanBullishKasar
$0.9752$0.9534$0.9316$0.9099$0.88811W AgoNow7D F

Analisis Teknis

MenjualNetralMembeli
Neutral
1
Bullish
3
Netral
1
Kasar

Indikator Utama

IndikatorNilaiSinyal
Price$0.9205 Mid
Daily Change-3.10% Below
Volatility Cap20.0% Mid
Confidence64% Above
Data Sourcenasdaq-screener Mid

Data Historis

Current$0.9205
Daily Change-3.10%
Market Cap$43.62M
Sourcenasdaq-screener
Current$0.9205Daily Change-3.10%
Market Cap$43.62MSourcenasdaq-screener

Level Dukungan & Resistensi

$0.8929Support 1
$0.9205Saat ini
$0.9481Resistance 1
shield
Support and resistance are estimated from the trusted current price until deeper historical data is available.

Tonggak Harga

Tingkatan kunci & konteks sejarah
Current$0.9205Live reference price
Used as the anchor for generated forecast calculations.
Next Month$0.9960Model projection+8.20%
Directional scenario based on capped drift.

Akurasi Perkiraan

Bagaimana kinerja model kami
64%
Terarah
Generated market-data forecast
This page uses live catalog market data and conservative volatility caps. It is informational, not financial advice.
📊
Algoritme kami dikalibrasi ulang setiap minggu menggunakan aksi harga terbaru, rezim volatilitas, dan sinyal indikator. Akurasi bervariasi berdasarkan jangka waktu — momentum jangka pendek lebih dapat diandalkan dibandingkan proyeksi jangka panjang.
Short term
64%
Direction confidence
Long term
Lower
Forecast uncertainty rises with horizon

Skenario Investasi

Jika Anda berinvestasi $1,000 di ZYBT hari ini
Bullish Scenario
$0.9665
+5.00% from current
Harga Sasaran$0.9665
SkenarioUpside momentum
Kemungkinan56%
Base Scenario
$0.9960
+8.20%
Harga Sasaran$0.9960
SkenarioCapped drift
Kemungkinan64%
Bearish Scenario
$0.8745
-5.00% from current
Harga Sasaran$0.8745
SkenarioVolatility drawdown
Kemungkinan36%
Dasar: Scenario model combines current spot price, recent market direction, and conservative asset-class volatility caps.

Faktor Ramalan

Market Structure
Price structure reflects the latest momentum regime and support/resistance interaction.
Momentum Bullish · 67/100
24H drift+1.24%
7D drift+3.85%
30D drift+8.20%
Technical Signals
Signals combine RSI, MACD, and moving average stacks to estimate short-term direction.
Mixed — Watching · 50/100
RSIn/a
MACDn/a
MA stackn/a
Macro Context
Rates, dollar strength, and cross-asset risk appetite influence medium-term paths.
Risk-On Tentative · 65/100
1M outlook+8.20%
1Y outlook+14.72%
5Y outlook+30.00%

Pertanyaan yang Sering Diajukan

Q What is the Zhengye Biotechnology Holding Limited Class A Ordinary Shares (ZYBT) forecast for tomorrow?
Using the latest BeCoin market snapshot (April 22 · 2026 at 07:03 UTC), Zhengye Biotechnology Holding Limited Class A Ordinary Shares is projected near $0.9319 versus the current reference around $0.9205. That implies a modeled move of +1.24% over the next day, with realized prices still sensitive to intraday volatility.
Q What does the 7-day stock outlook suggest for ZYBT?
The weekly Zhengye Biotechnology Holding Limited Class A Ordinary Shares model points to $0.9559, which maps to an expected drift of +3.85% from current conditions. This horizon reacts quickly to momentum shifts, so support/resistance breaks can change the path faster than long-term targets.
Q How should I read the Zhengye Biotechnology Holding Limited Class A Ordinary Shares 1-month and 1-year targets?
The Zhengye Biotechnology Holding Limited Class A Ordinary Shares 1-month target is $0.9960 (+8.20%), while the 1-year target is $1.06 (+14.72%). The monthly view tracks prevailing trend pressure, and the yearly view reflects broader cycle assumptions shaped by price momentum, liquidity, and company-specific risk.
Q Why does the Zhengye Biotechnology Holding Limited Class A Ordinary Shares 5-year scenario differ from short-term rows?
The Zhengye Biotechnology Holding Limited Class A Ordinary Shares long-horizon scenario sits near $1.20 with a modeled change of +30.00%. It compounds cycle-continuation assumptions over time, so it should be treated as a scenario envelope rather than a precise endpoint.
Q Where are ZYBT support and resistance zones right now?
For Zhengye Biotechnology Holding Limited Class A Ordinary Shares, nearest resistance is around $0.8929, while nearest support is around $0.9481. A clean break above resistance improves continuation odds, while repeated closes under support raise downside risk.
Q How fresh is the Zhengye Biotechnology Holding Limited Class A Ordinary Shares market snapshot?
The displayed stock snapshot is labeled April 22 · 2026 at 07:03 UTC; the latest observed session range is roughly n/a to n/a. These checkpoints are rebuilt from the market feed so the FAQ, milestones, and support/resistance context stay tied to the same data refresh.